Aspen Aerogels (ASPN): Evaluating Valuation After Lowered 2025 Outlook and Larger Projected Net Loss

Simply Wall St.11-15

Aspen Aerogels (ASPN) just released third quarter earnings, lowering its revenue and earnings outlook for the rest of 2025. Sales fell sharply year-over-year, and the company now anticipates a larger ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583706633?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/1022000-choice2-main-header/1585186558401","is_english":true,"pubTime":"2025-11-15 07:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583706633","market":"sg","top_or_hot":-1,"title":"Aspen Aerogels (ASPN): Evaluating Valuation After Lowered 2025 Outlook and Larger Projected Net Loss","media":"Simply Wall St.","content":"<div>\n<p>Aspen Aerogels (ASPN) just released third quarter earnings, lowering its revenue and earnings outlook for the rest of 2025. Sales fell sharply year-over-year, and the company now anticipates a larger ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-aspn/aspen-aerogels/news/aspen-aerogels-aspn-evaluating-valuation-after-lowered-2025\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aspen Aerogels (ASPN): Evaluating Valuation After Lowered 2025 Outlook and Larger Projected Net Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAspen Aerogels (ASPN): Evaluating Valuation After Lowered 2025 Outlook and Larger Projected Net Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-15 07:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/materials/nyse-aspn/aspen-aerogels/news/aspen-aerogels-aspn-evaluating-valuation-after-lowered-2025><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Aspen Aerogels (ASPN) just released third quarter earnings, lowering its revenue and earnings outlook for the rest of 2025. Sales fell sharply year-over-year, and the company now anticipates a larger ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-aspn/aspen-aerogels/news/aspen-aerogels-aspn-evaluating-valuation-after-lowered-2025\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"1F3.SI","symbol_name":"Aspen","start_time":0,"source_url":"https://simplywall.st/stocks/us/materials/nyse-aspn/aspen-aerogels/news/aspen-aerogels-aspn-evaluating-valuation-after-lowered-2025","article_id":"2583706633","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/1022000-choice2-main-header/1585186558401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-aspn/aspen-aerogels/news/aspen-aerogels-aspn-evaluating-valuation-after-lowered-2025","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2583706633","pubTimestamp":1763163373,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Aspen Aerogels (ASPN) just released third quarter earnings, lowering its revenue and earnings outlook for the rest of 2025. Sales fell sharply year-over-year, and the company now anticipates a larger annual net loss, including a hefty impairment charge.\nSee our latest analysis for Aspen Aerogels.\nIt’s been a punishing year for Aspen Aerogels after a string of disappointing results and lowered guidance. The share price has tumbled 65% in the last month, and the one-year total shareholder...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"1F3.SI":"Aspen","ASPN":"Aspen Aerogels","IE00B7SZL793.SGD":"Legg Mason Royce - US Small Cap Opportunity A Acc SGD-H","IE00B19Z4B17.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) ACC","BK4109":"特种化学制品","IE00B66KJ199.SGD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY  \" A\" (SGD) ACC","BK6512":"房地产股","BK6117":"房地产开发","BK4179":"石油天然气设备与服务","IE0031619046.USD":"LEGG MASON ROYCE US SMALL CAP OPPORTUNITY \"A\" (USD) INC"},"translate_title":"Aspen Aerogels(ASPN)：在下调2025年前景和扩大预计净亏损后评估估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"1F3.SI":0.9,"ASPN":1.5},"content_text":"Aspen Aerogels (ASPN) just released third quarter earnings, lowering its revenue and earnings outlook for the rest of 2025. Sales fell sharply year-over-year, and the company now anticipates a larger annual net loss, including a hefty impairment charge. See our latest analysis for Aspen Aerogels. It’s been a punishing year for Aspen Aerogels after a string of disappointing results and lowered guidance. The share price has tumbled 65% in the last month, and the one-year total shareholder return has dropped 78%. Momentum has clearly faded as investors digest lower forecasts, impairment charges, and sharper realized losses. If you’re looking for other opportunities beyond recent disappointments, now’s the perfect time to broaden your horizons and discover fast growing stocks with high insider ownership With the share price at multiyear lows and analyst targets suggesting significant upside, the question now is whether Aspen Aerogels is undervalued after this steep selloff or if the market is still factoring in further challenges ahead. AdvertisementMost Popular Narrative: 64.8% Undervalued According to the most widely followed narrative, Aspen Aerogels’ fair value massively exceeds its last close price. This suggests a deep disconnect between current market sentiment and anticipated recovery. The narrative includes ambitious profit and revenue assumptions and lays out a roadmap for earnings acceleration, presenting a stark contrast to recent results.  Aspen's cost optimization, which has reduced fixed costs by approximately $65M and streamlined operations, substantially lowers the revenue threshold needed to achieve profitability. This greater operating leverage, combined with a stable cost structure and controlled capital expenditures, is set to significantly improve EBITDA and net margin even at modest revenue recovery.  Read the complete narrative. Curious what delivers such a high valuation target? The narrative highlights a potential transformation built on a few critical, and possibly controversial, assumptions. Dramatic shifts in profit and top-line growth drive its outlook. Uncover the full financial leap powering this bold fair value estimate and see what might surprise you in the details. Result: Fair Value of $8.75 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, slower-than-expected recovery in energy industrial demand or ongoing volatility in key EV policies could quickly challenge these optimistic projections. Find out about the key risks to this Aspen Aerogels narrative.  Build Your Own Aspen Aerogels Narrative If you believe there’s more to the story, or want to dive into the numbers yourself, you can generate your own view in just minutes: Do it your way A great starting point for your Aspen Aerogels research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Looking for More Smart Investment Moves? Expand your investing edge and seize fresh opportunities that others might overlook. Don’t let today’s volatility distract you from companies with powerful growth or income potential.  Target high yields and long-term income potential when you review these 16 dividend stocks with yields > 3% with attractive returns over 3%. Spot emerging trends and stay ahead by evaluating these 25 AI penny stocks as these companies are redefining industries with artificial intelligence. Accelerate your search for value by checking out these 877 undervalued stocks based on cash flows to see which stocks stand out based on robust cash flow analysis.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583706633","isCrawlerRequest":true}